Clinical Trial Update: Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND) [Phase 2]

View source ↗

Summary

Phase II study comparing LR-GEM to R-GEM-P in second-line treatment of diffuse large B-cell lymphoma is ongoing/unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: UNKNOWN